Blocklisting Interim Review

Evolution Group PLC 24 August 2005 SCHEDULE 5 BLOCKLISTING SIX MONTHLY RETURN To: Listing Applications UK Listing Authority Financial Services Authority 25, The North Colonnade Canary Wharf London, E14 5HS Please ensure the entries on this return are typed 1. Name of company The Evolution Group Plc 2. Name of scheme (1) The Evolution Group Plc 2003 Share Incentive Plan (2) The Ex Beeson Gregory Group Plc Share Incentive Scheme 1996 3. Period of return: From 24 February 2005 To 22 August 2005 4. Number and class of shares(s) (amount of stock / debt security) not issued under scheme (as referred to in 2. above) (1) 315,793 Ordinary 1p Shares (2) Nil Ordinary 1p Shares 5. Number of shares issued / allotted under scheme (as referred to in 2. above) during period: (1) 50,431 Ordinary 1p Shares (2) Nil 6. Balance under scheme (as referred to in 2. above) not yet issued / allotted at end of period (1) 315,793 Ordinary 1p Shares (2) Nil Ordinary 1p Shares 7. Number and class of share(s) (amount of stock / debt securities) originally listed and the date of admission: Total of 588,500 Ordinary Shares of 1p each on 27 February 2004 including (1) 500,000 Ordinary 1p Shares under Scheme 1 above (2) 88,500 Ordinary 1p Shares under Scheme 2 above Please confirm total number of shares in issue at the end of the period in order for us to update our records 222,133,300 (excluding balance of shares in Block Listings) 223,846,293 (including balance of shares in Block Listings) Contact for queries Name Yew Meng Fong / Graeme Dell Address 9th Floor, 100 Wood Street, London EC2V 7AN Telephone 020 7071 4300 Person making the return Name Yew Meng Fong Position Company Secretary Signature The FSA does not give any express or implied warranty as to the accuracy of this document or material and does not accept any liability for error or omission. The FSA is not liable for any damages (including, without limitation, damages for loss of business or loss of profits) arising in contract, tort or otherwise from the use of or inability to use this document, or any material contained in it, or from any action or decision taken as a result of using this document or any such material. This information is provided by RNS The company news service from the London Stock Exchange BLRBLGDIBSDGGUS

Companies

Evgen Pharma (EVG)
UK 100

Latest directors dealings